Jianjun Liu and colleagues found that CBF (Cinobufotalin) selectively inhibits SREBP1 expression and interacts with SREBP1 to prevent its binding to SREs, thereby inhibiting the expression of lipogenic enzymes and reducing tumor volume and weight in tumor‐bearing mice [99]. Here, CEBPZ is linked to neoplasm.